Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)

NCT ID: NCT04075084

Last Updated: 2025-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-28

Study Completion Date

2027-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This registry is performed for the long-term assessment of outcome, performance and residual safety aspects of the BIOMONITOR III and possible successors in a real-life clinical set-up. In addition, this registry is set up in a way that it may also be used as a platform for submodules to investigate additional scientific and regulatory aspects while minimizing the additional effort for the investigational sites and patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tachycardia Atrial Fibrillation Syncope Bradycardia Cryptogenic Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is intended to receive a BIOTRONIK Implantable Cardiac Monitor (ICM)
* Patient is able to understand the nature of the registry and to provide written informed consent.
* Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept.

Exclusion Criteria

* Patient is pregnant or breast feeding.
* Patient is less than 18 years old.
* Patient is participating in another interventional clinical investigation other than the submodules of BIO\|STREAM.ICM
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biotronik SE & Co. KG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Integral Health

Adelaide, , Australia

Site Status RECRUITING

Royal Adelaide Hospital

Adelaide, , Australia

Site Status COMPLETED

Nemocnice Ceske Budejovice, a.s.

České Budějovice, , Czechia

Site Status RECRUITING

Hôpital Saint-André

Bordeaux, , France

Site Status COMPLETED

Le Centre Hospitalier Universitaire de Brest (CHRU Brest)

Brest, , France

Site Status RECRUITING

Le Centre Hospitalier Universitaire de Caen (CHRU Caen)

Caen, , France

Site Status RECRUITING

Le Centre Hospitalier Universitaire de Tours (CHRU Tours)

Chambray-lès-Tours, , France

Site Status ACTIVE_NOT_RECRUITING

Hôpital Gabriel Montpied

Clermont-Ferrand, , France

Site Status RECRUITING

Hôpital Haut Lévêque (CHU)

Pessac, , France

Site Status RECRUITING

Hôpitaux Universitaires de Strasbourg

Strasbourg, , France

Site Status RECRUITING

St. Marienkrankhaus Klinikum Westmünsterland GmbH

Ahaus, , Germany

Site Status RECRUITING

Kerckhoff-Klinik GmbH

Bad Nauheim, , Germany

Site Status RECRUITING

Rhön-Klinikum

Bad Neustadt an der Saale, , Germany

Site Status ACTIVE_NOT_RECRUITING

Universitätsklinik an der Technischen Universität Dresden

Dresden, , Germany

Site Status COMPLETED

Helios Klinikum Erfurt

Erfurt, , Germany

Site Status RECRUITING

Klinikum Herford

Herford, , Germany

Site Status RECRUITING

Helios Health Institute GmbH

Leipzig, , Germany

Site Status RECRUITING

Deutsches Herzzentrum der Charité

Mitte, , Germany

Site Status RECRUITING

Klinikum rechts der Isar der Technischen Universität München

München, , Germany

Site Status ACTIVE_NOT_RECRUITING

Deutsches Herzzentrum der Charité

Steglitz, , Germany

Site Status RECRUITING

Ospedale Civile Ferrari

Castrovillari, , Italy

Site Status RECRUITING

Ospedale Maria Vittoria

Torino, , Italy

Site Status RECRUITING

Pauls Stradins Clinical University Hospital

Riga, , Latvia

Site Status RECRUITING

Unidade Local de Saúde do Alto Ave, E. P. E.

Guimarães, , Portugal

Site Status RECRUITING

Unidade Local de Saúde de Santa Maria, E. P. E.

Lisbon, , Portugal

Site Status RECRUITING

Centro Médico Teknon

Erandio, , Spain

Site Status RECRUITING

Hospital de Fuenlabrada

Fuenlabrada, , Spain

Site Status ACTIVE_NOT_RECRUITING

Hospital Álvaro Cunqueiro

Vigo, , Spain

Site Status RECRUITING

Hospital Universitario de Araba

Vitoria-Gasteiz, , Spain

Site Status RECRUITING

GZO Spital Wetzikon

Wetzikon, , Switzerland

Site Status COMPLETED

Universitätsspital Zürich (USZ)

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Australia Czechia France Germany Italy Latvia Portugal Spain Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sabrina Hoche, Dr.

Role: CONTACT

+49 30 68905 ext. 1337

Dörte Vossmeyer, Dr.

Role: CONTACT

+49 30 68905 ext. 1306

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dennis Lau, Dr.

Role: primary

Alan Bulava, Prof.

Role: primary

Jacques Mansourati, Pr.

Role: primary

Virgine Ferchaud, Dr

Role: primary

Romain Eschalier, Pr.

Role: primary

Sylvain Ploux, Pr.

Role: primary

Laurence Jesel-Morel, Dr.

Role: primary

Alessandro Cueno, Dr.

Role: primary

Andreas Hain, Dr.

Role: primary

Frank Steinborn, Dr.

Role: primary

Jan Kähler, Prof. Dr.

Role: primary

Sotirios Nedios, Dr.

Role: primary

Verena Tscholl, Dr.

Role: primary

Patrick Nagel, Dr.

Role: primary

Giovanni Bisignani, Dr.

Role: primary

Massimo Giammaria, Dr.

Role: primary

Andrejs Erglis, Prof

Role: primary

Victor M. Sanfins, Dr.

Role: primary

João de Sousa, Dr.

Role: primary

Antonio Berruezo Sanchez, Dr.

Role: primary

Pilar Cabanas, Dr.

Role: primary

Enrique Garcia, Dr.

Role: primary

Daniel Hofer, Dr.

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Bisignani G, De Bonis S, Pierre B, Lau DH, Hofer D, Sanfins VM, Hain A, Cabanas P, Martens E, Berruezo A, Eschalier R, Milliez P, Lusebrink U, Mansourati J, Papaioannou G, Giacopelli D, Gargaro A, Ploux S. Insertable cardiac monitor with a long sensing vector: Impact of obesity on sensing quality and safety. Front Cardiovasc Med. 2023 Mar 21;10:1148052. doi: 10.3389/fcvm.2023.1148052. eCollection 2023.

Reference Type DERIVED
PMID: 37025684 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HS061

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BIOSTREAM.HF HeartInsight
NCT05761249 COMPLETED
Physiologic Pacing Registry
NCT03719040 COMPLETED
BIO.MASTER.BioMonitor 2 Study
NCT02565238 COMPLETED
ProMRI 3T ENHANCED Master Study
NCT02506569 COMPLETED